Was Jim Cramer Right About These 12 Stocks?

7. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 92

Back in 2024, on May 17, a caller asked about Pfizer Inc. (NYSE:PFE), which had struggled post-COVID. Cramer said the turnaround was underway and highlighted the stock’s dividend and pipeline, saying:

“I like Pfizer here. It’s making a big turn — people don’t even seem to be aware of it. I’ve been talking about it every day in the office. I keep saying, ‘Has anyone watched this turn in Pfizer?’ 5.8% yield. I always liked Seagen, which is the old Seattle Genetics — I think Dr. Bourla’s got it right. They have a lot of cash. Yes — Pfizer is a buy.”

Pfizer failed to deliver the turnaround Cramer expected, with shares down 21.06% since his buy recommendation.

Pfizer Inc. (NYSE:PFE) is struggling to reassure investors despite a strong dividend and recent oncology-focused acquisitions. When asked about it again recently, Cramer stated that he remains a believer in the stock. Here’s what he said on May 12:

“You know, look, I think Pfizer, I think it can bottom here. I do believe, I still believe in the Seagen acquisition. I know I seem like, that I’m alone along with Dr. Bourla, but I think that there’s a lot of good stuff that they have, so I would say keep it here.”